[1] Dubey S, Biswas P, Ghosh R, Chatterjee S, Kanti Ray B, Benito-Leon J. Neuroimaging of diabetic striatopathy: more questions than answers. Eur Neurol. 2022;85(5):371-376.
[2] Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am. 2021;50(3):337-55.
[3] Aschner P, Karuranga S, James S, Simmons S, Basit A, Shaw JE, et al. The International Diabetes Federation's guide for diabetes epidemiological studies. Diabetes Res Clin Pract. 2021 Feb:172:108630.
[4] Shojima N, Yamauchi T. Progress in genetics of type 2 diabetes and diabetic complications. J Diabetes Investig. 2023;14(4):503-15.
[5] Mallet V, Parlati L, Martinino A, Pereira JPS, Jimenez CN, Sakka M, et al. Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. J Hepatol. 2022;76(2):265-74.
[6] Molinaro A, Becattini B, Solinas G. Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype. Sci Rep. 2020;10(1):12031.
[7] Dewidar B, Kahl S, Pafili K, Roden M. Metabolic liver disease in diabetes–from mechanisms to clinical trials. Metabolism. 2020;111:154299.
[8] A Adeshara K, G Diwan A, S Tupe R. Diabetes and complications: cellular signaling pathways, current understanding and targeted therapies. Curr Drug Targets. 2016;17(11):1309-28.
[9] Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J. 2012;12(1):5.
[10] Goboza M, Aboua YG, Chegou N, Oguntibeju OO. Vindoline effectively ameliorated diabetes-induced hepatotoxicity by docking oxidative stress, inflammation and hypertriglyceridemia in type 2 diabetes-induced male Wistar rats. Biomed Pharmacother. 2019;112:108638.
[11] Mohamed J, Nafizah AN, Zariyantey A, Budin S. Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. Sultan Qaboos Univ Med J. 2016;16(2):e132.
[12] Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 2003;12(1):44-50.
[13] Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90(1):37-43.
[14] Arjmand Abbassi Y, Mohammadi MT, Sarami Foroshani M, Raouf Sarshoori J. Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat. Adv Pharm Bull. 2016;6(4):531-9.
[15] Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975;85(2):337-41.
[16] Vani JR, Mohammadi MT, Foroshani MS, Jafari M. Polyhydroxylated fullerene nanoparticles attenuate brain infarction and oxidative stress in rat model of ischemic stroke. EXCLI journal. 2016;15:378-90.
[17] Mohammadi MT. Overproduction of nitric oxide intensifies brain infarction and cerebrovascular damage through reduction of claudin-5 and ZO-1 expression in striatum of ischemic brain. Pathol Res Pract. 2016;212(11):959-64.
[18] Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction. Bull Exp Biol Med. 2021;171(2):179-89.
[19] Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176:113869.
[20] Drummer Ct, Saaoud F, Jhala NC, Cueto R, Sun Y, Xu K, et al. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. Front Immunol. 2023;14:1113883.
[21] Zhijun K, Xudong Z, Baoqiang W, Chunfu Z, Qiang Y, Yuan G, et al. Increased oxidative stress caused by impaired mitophagy aggravated liver ischemia and reperfusion injury in diabetic mice. J Diabetes Investig. 2023;14(1):28-36.
[22] Ménégaut L, Laubriet A, Crespy V, Leleu D, Pilot T, Van Dongen K, et al. Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis. Cardiovasc Diabetol. 2023;22(1):248.
[23] Hazem RM, Ibrahim AZ, Ali DA, Moustafa YM. Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation. Int Immunopharmacol. 2022;104:108503.
[24] An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023;22(1):237.
[25] Batirel S, Bozaykut P, Mutlu Altundag E, Kartal Ozer N, Mantzoros CS. The effect of Irisin on antioxidant system in liver. Free Radic Biol Med. 2014;75 Suppl 1:S16.
[26] Giribabu N, Karim K, Kilari EK, Kassim NM, Salleh N. Anti-Inflammatory, Antiapoptotic and Proproliferative Effects of Vitis vinifera Seed Ethanolic Extract in the Liver of Streptozotocin-Nicotinamide-Induced Type 2 Diabetes in Male Rats. Can J Diabetes. 2018;42(2):138-49.
[27] Li J, Wang T, Liu P, Yang F, Wang X, Zheng W, et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 2021;12(9):3898-918.
[28] Kim HY, Noh JR, Moon SJ, Choi DH, Kim YH, Kim KS, et al. Sicyos angulatus ameliorates acute liver injury by inhibiting oxidative stress via upregulation of anti-oxidant enzymes. Redox Rep. 2018;23(1):206-12.
[29] Nobili V, Pastore A, Gaeta LM, Tozzi G, Comparcola D, Sartorelli MR, et al. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta. 2005;355(1-2):105-11.
[30] Cunningham RP, Moore MP, Dashek RJ, Meers GM, Takahashi T, Sheldon RD, et al. Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH. Diabetes. 2021;70(11):2476-91.
[31] Chao J, Bledsoe G, Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. 2016;68(3):533-41.
[32] Jeddi S, Gheibi S, Carlström M, Kashfi K, Ghasemi A. Long-term co-administration of sodium nitrite and sodium hydrosulfide inhibits hepatic gluconeogenesis in male type 2 diabetic rats: Role of PI3K-Akt-eNOS pathway. Life Sci. 2021;265:118770.
[33] Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell and tissue research. 2009;335(1):165-89.
[34] Jiang R, Zhang H, Liu Q, Yang X, He L, Yuan L, et al. De Novo Design of Near-Infrared Fluorescent Agents Activated by Peroxynitrite and Glutathione-Responsive Imaging for Diabetic Liver Disease. Adv Healthc Mater. 2024;13(2):e2302466.
[35] Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436-43.
Pathobiology Reserach